Difficulty: Medium
Average Score: 65%
Practice
Which one of the following statements about vigabatrin is accurate?
Correct answer
B
Rationale
In this question, the correct answer is B) Causes visual field defects in up to one-third of patients.
Rationale:
Vigabatrin is an antiepileptic drug that is known to cause visual field defects, particularly concentric visual field constriction, in a significant number of patients. This adverse effect is due to the drug's mechanism of action, which involves irreversibly inhibiting the enzyme GABA-transaminase, leading to increased levels of GABA in the brain. The visual field defects are a well-documented and serious side effect of vigabatrin therapy.
Option A) Blocks neuronal reuptake of GABA is incorrect because vigabatrin does not act by blocking the reuptake of GABA. Instead, it increases GABA levels by inhibiting its breakdown.
Option C) Established teratogen in humans is incorrect because while vigabatrin has been associated with developmental abnormalities in animal studies, its teratogenic effects in humans are not well established.
Option D) May cause life-threatening skin disorders is incorrect because life-threatening skin disorders are not a commonly reported side effect of vigabatrin. The most concerning side effect associated with vigabatrin use is the development of visual field defects.
Educational Context:
Understanding the side effects and mechanisms of action of CNS drugs like vigabatrin is crucial for healthcare professionals, particularly those working in neurology, psychiatry, or pharmacy. Knowledge of the potential adverse effects of medications allows for informed decision-making when prescribing or monitoring patients on these drugs. It also highlights the importance of patient education and close monitoring for any concerning symptoms while on vigabatrin therapy.
Rationale:
Vigabatrin is an antiepileptic drug that is known to cause visual field defects, particularly concentric visual field constriction, in a significant number of patients. This adverse effect is due to the drug's mechanism of action, which involves irreversibly inhibiting the enzyme GABA-transaminase, leading to increased levels of GABA in the brain. The visual field defects are a well-documented and serious side effect of vigabatrin therapy.
Option A) Blocks neuronal reuptake of GABA is incorrect because vigabatrin does not act by blocking the reuptake of GABA. Instead, it increases GABA levels by inhibiting its breakdown.
Option C) Established teratogen in humans is incorrect because while vigabatrin has been associated with developmental abnormalities in animal studies, its teratogenic effects in humans are not well established.
Option D) May cause life-threatening skin disorders is incorrect because life-threatening skin disorders are not a commonly reported side effect of vigabatrin. The most concerning side effect associated with vigabatrin use is the development of visual field defects.
Educational Context:
Understanding the side effects and mechanisms of action of CNS drugs like vigabatrin is crucial for healthcare professionals, particularly those working in neurology, psychiatry, or pharmacy. Knowledge of the potential adverse effects of medications allows for informed decision-making when prescribing or monitoring patients on these drugs. It also highlights the importance of patient education and close monitoring for any concerning symptoms while on vigabatrin therapy.